Hansa Medical's CEO Göran Arvidson has suddenly and unexpectedly passed away

It was with great grief that on November 8, 2017, Hansa Medical announced the passing of Göran Arvidson. His death is both deeply tragic and completely unexpected.

Göran Arvidson was recruited to Hansa Medical as CFO in January 2015. He became acting CEO shortly afterwards and was appointed permanent CEO on April 30 the same year. He has had long and successful career in the pharmaceutical industry, including senior positions at Pharmacia and later Biovitrum (Sobi), where he was one of the founders.

With his solid experience from the pharmaceutical industry and through his deep and genuine commitment, Göran has been an appreciated and accomplished leader for Hansa Medical, which, under his leadership, has developed into a promising pharmaceutical company with its lead project IdeS currently in late-stage clinical development for kidney transplant patients.

Ulf Wiinberg, chairman of Hansa Medical, will serve as acting CEO and board member Birgit Stattin Norinder will take over the role as chairman of the board until further notice.